Martingale Asset Management »

Mineralys Therapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Mineralys Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 29181k182k183k184k14.964k14.9645k14.965k14.9655k14.966k
Value ($)Share countHistorical MLYS position of Martingale Asset Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $184k 15k 12.31
2024-09-30 $181k 15k 12.11

More positions owned by Martingale Asset Management

Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Facebook Inc cl a (META)
Visa (V)
At&t (T)
Cisco Systems (CSCO)
UnitedHealth (UNH)
Costco Wholesale Corporation (COST)
MasterCard Incorporated (MA)
Exxon Mobil Corporation (XOM)

View all positions for Martingale Asset Management

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics